The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
Abstract
Messenger RNA (mRNA) has received great attention in the prevention and treatment of various diseases due to the success of coronavirus disease 2019 (COVID‐19) mRNA vaccines (Comirnaty and Spikevax). To meet the therapeutic purpose, it is required that mRNA must enter the target cells and express sufficient proteins. Therefore, the development of effective delivery systems is necessary and crucial. Lipid nanoparticle (LNP) represents a remarkable vehicle that has indeed accelerated mRNA applications in humans, as several mRNA‐based therapies have already been approved or are in clinical trials. In this review, the focus is on mRNA‐LNP‐mediated anticancer therapy. It summarizes the main development strategies of mRNA‐LNP formulations, discusses representative therapeutic approaches in cancer, and points out current challenges and possible future directions of this research field. It is hoped that these delivered messages can help further improve the application of mRNA‐LNP technology in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Cytokines that target immune killer cells against tumors
Qiao, J., & Fu, Y. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0481-0 · Cited by 37
Jin, H. K., Jeong, M., Lee, G., Kim, M., Yoo, Y., Kim, H. J., Cho, J., Lee, Y., & Lee, H. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202209432 · Cited by 37
Sakurai, Y., Hada, T., Kato, A., Hagino, Y., Mizumura, W., & Harashima, H. (2018) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2018.10.004 · Cited by 35
Amant, A. H. S., Huang, F., Lin, J., Rickert, K. W., Oganesyan, V., Lemen, D., Mao, S., Harper, J. W., Marelli, M., Wu, H., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903494 · Cited by 35
Bax mRNA therapy using cationic liposomes for human malignant melanoma
Okumura, K., Nakase, M., Inui, M., Nakamura, S., Watanabe, Y., & Tagawa, T. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1214 · Cited by 31
Lipidoid Tail Structure Strongly Influences siRNA Delivery Activity
Knapp, C. M., Guo, P., & Whitehead, K. A. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0436-9 · Cited by 27
Yu, S.-Y., Carlaw, T., Thomson, T., Birkenshaw, A., Basha, G., Kurek, D. Z., Huang, C., Kulkarni, J. A., Zhang, L., & Ross, C. J. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.009 · Cited by 27
Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine
Abdellatif, A. A. H., Younis, M. A., Alsowinea, A. F., Abdallah, E. M., Abdel‐Bakky, M. S., Al-Subaiyel, A., Hassan, Y. A., & Tawfeek, H. M. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.113111 · Cited by 25
Yu, X., Liu, S., Cheng, Q., Lee, S. M., Wei, T., Zhang, D., Farbiak, L., Johnson, L. T., Wang, X., & Siegwart, D. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111914 · Cited by 21
Self-citationMu, Q., Annapragada, A. V., Srivastava, M., Li, X., Wu, J. G., Thiviyanathan, V., Wang, H., Williams, A. G., Gorenstein, D. G., Annapragada, A., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.81 · Cited by 20
Lipid nanoparticles for mRNA therapy: recent advances in targeted delivery
Wei, T., Tao, W., & Cheng, Q. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac004 · Cited by 15
Self-citation
Cited by
Isaac, I., Patel, L., Tran, N., Singam, A., Yun, D., Guha, P., Park, S., & Bhattacharya, C. (2025) · Advanced Materials · doi:10.1002/adma.202507657 · Cited by 33
Ye, L., Zhao, G., Ma, J., Gan, Q., Luo, N., Pan, D., Chen, C., Chen, X., & Ning, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02769-3 · Cited by 10
Li, P., Dong, Z., Jiang, Q., Yu, C., Liu, Y., Yuan, R., Qiu, Y., Meng, T., Hu, F., & Yuan, H. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114406 · Cited by 6
RNALens: Study on 5’ UTR Modeling and Cell-Specificity
Mao, L., Tian, Y., Qian, K.-W., & Song, Y. (2025) · doi:10.1101/2025.07.20.665722 · Cited by 1
Metadata
- Authors
- Zong, Y., Lin, Y., Wei, T., & Cheng, Q.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2023-11
- Volume
- 35
- Issue
- 51
- Pages
- e2303261-e2303261
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W4376868041
- Cited by
- 477
- References
- 211
- FWCI
- 35.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.